Mostrar el registro sencillo del ítem
Autor | Bessa, Theolis Costa Barbosa | |
Autor | Aragão, Erika Santos de | |
Autor | Guimarães, Jane Mary Medeiros | |
Autor | Almeida, Bethânia de Araújo | |
Fecha de acceso | 2018-02-26T18:46:41Z | |
Fecha de disponibilización | 2018-02-26T18:46:41Z | |
Fecha de publicación | 2017 | |
Referencia | BESSA, T. C. B. et al. R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014. BioMed Research International, ID 4765719, 2017. | pt_BR |
ISSN | 2314-6133 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/24949 | |
Promoción | National Institute of Science and Technology of Innovation onDiseases of Neglected Populations (INCT-IDPN), | pt_BR |
Idioma | eng | pt_BR |
Editor | Hindawi Publishing Corporation | pt_BR |
Derechos de autor | open access | pt_BR |
Palabras clave en Portugués | Doenças negligenciadas | pt_BR |
Palabras clave en Portugués | Tuberculose | pt_BR |
Palabras clave en Portugués | Vacinas contra a tuberculose | pt_BR |
Palabras clave en Portugués | Pesquisa | pt_BR |
Palabras clave en Portugués | Ensaios clínicos como assunto | pt_BR |
Título | R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014 | pt_BR |
Tipo del documento | Article | pt_BR |
DOI | 10.1155/2017/4765719 | |
Resumen en Inglés | Based on an exploratory case study regarding the types of institutions funding the research and development to obtain new tuberculosis vaccines, this article intends to provoke discussion regarding the provision of new vaccines targeting neglected disease. Although our findings and discussion are mainly relevant to the case presented here, some aspects are more generally applicable, especially regarding the dynamics of development in vaccines to prevent neglected diseases. Taking into account the dynamics of innovation currently seen at work in the vaccine sector, a highly concentrated market dominated by few multinational pharmaceutical companies, we feel that global PDP models can play an important role throughout the vaccine development cycle. In addition, the authors call attention to issues surrounding the coordination of actors and resources in the research, development, manufacturing, and distribution processes of vaccine products arising from PDP involvement. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil | pt_BR |
Afiliación | Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil | pt_BR |
Afiliación | Federal University of Southern Bahia. Institute of Humanities Arts and Sciences. Itabuna, BA, Brazil | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil | pt_BR |
Palavras clave en Inglês | Neglected Diseases | pt_BR |
Palavras clave en Inglês | Tuberculosis | pt_BR |
Palavras clave en Inglês | Tuberculosis Vaccines | pt_BR |
Palavras clave en Inglês | Research | pt_BR |
Palavras clave en Inglês | Clinical trials as subject | pt_BR |